Vaccination improves livability and performance in commercial flocks affected by necrotic enteritis

Commercial trials have demonstrated the efficacy of Avert® NE from Huvepharma against necrotic enteritis in commercial broiler facilities. David Smith, DVM, MS, director of poultry technical services at Huvepharma discussed these trials, which evaluated livability and zootechnical performance of birds given the vaccine, pointing to improvements in vaccinated flocks compared to unvaccinated birds.